Roundtable Discussion: How Are Bispecifics Expanding Beyond Oncology to Address Unmet Need in Chronic Disease?
10:10 am - Thursday 9th July 2026
- Where do bispecifics truly outperform monoclonals or RNA therapies in chronic, non-oncology diseases?
- How should bispecifics be designed to unlock new biology beyond immune effector functions?
- What needs to change in biomarkers, dosing, and trial design to prove value outside oncology?
